Vensana Capital Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
9
- Investments
-
32
- Portfolio
-
16
- Exits
-
7
Vensana Capital General Information
Company Description
Founded in 2019, Vensana Capital is a venture capital and growth equity firm based in Minneapolis, Minnesota. The firm seeks to invest in medtech companies operating in the medical devices, data science-oriented solutions, life science tools & diagnostics, and tech-enabled services sectors. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.vensanacap.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 3601 West 76th Street
- Suite 20
- Minneapolis, MN 55435
- United States
Vensana Capital Investments (32)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| SpyGlass Pharma | 02-Jun-2025 | Later Stage VC | Surgical Devices | Clinical Trials - General | ||
| Rampart IC | 24-Apr-2025 | Other Devices and Supplies | Generating Revenue | |||
| Evident Vascular | 25-Mar-2025 | Diagnostic Equipment | Generating Revenue | |||
| ChromaCode | 30-Jan-2025 | Diagnostic Equipment | Generating Revenue | |||
| Alleviant Medical | 14-Jan-2025 | Therapeutic Devices | Clinical Trials - General | |||
| Okami Medical | 21-Oct-2024 | Surgical Devices | Generating Revenue | |||
| iVEAcare | 12-Apr-2024 | Decision/Risk Analysis | Startup | |||
| Elucent Medical | 02-Apr-2024 | Surgical Devices | Generating Revenue | |||
| Evident Vascular | 17-Oct-2023 | Early Stage VC | Diagnostic Equipment | Generating Revenue | ||
| SpyGlass Pharma | 10-Jul-2023 | Later Stage VC | Surgical Devices | Clinical Trials - General |
Vensana Capital Exits (7)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| Artelon | 11-Jul-2024 | Merger/Acquisition | |
| Relievant | 17-Nov-2023 | ||
| Monteris Medical | 01-May-2022 | ||
| Personal Genome Diagnostics | 18-Feb-2022 | ||
| Vesper Medical | 11-Jan-2022 | ||
| Barostim | 30-Jun-2021 | IPO | |
| Intact Vascular | 04-Sep-2020 | Merger/Acquisition |
Vensana Capital Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
Vensana Capital Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
Vensana Capital Co-Investors (60)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| Gilde Healthcare | 3 |
|
|
||
| Sands Capital |
|
|
|||
| Broadview Ventures |
|
|
|||
| New Enterprise Associates |
|
|
|||
| Piper Sandler |
|
|
Vensana Capital FAQs
-
What is Vensana Capital?
Founded in 2019, Vensana Capital is a venture capital and growth equity firm based in Minneapolis, Minnesota.
-
When was Vensana Capital founded?
Vensana Capital was founded in 2019.
-
Where is Vensana Capital headquartered?
Vensana Capital is headquartered in Minneapolis, MN.
-
What is Vensana Capital's total asset value?
Vensana Capital has around in total assets under management.
-
How many investments has Vensana Capital made?
Vensana Capital has made 32 investments.
-
What has Vensana Capital invested in?
Vensana Capital has made numerous investments in companies like SpyGlass Pharma, Rampart IC, and Evident Vascular within the Surgical Devices, Devices and Supplies, and Diagnostic Equipment industries.
-
What has Vensana Capital invested in recently?
Vensana Capital's latest investment was on 02-Jun-2025 in SpyGlass Pharma, a company within the Surgical Devices industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
